Top Companies in Biotechnology Market by Size, Share, Historical and Future Data & CAGR | Report by Vantage Market Research
Biotechnology Market is projected to reach a value of USD 2772.7 Billion by 2028 at a CAGR of 14.2% over the forecast period.
Vantage Market Research has recently published a new report on "Biotechnology Market” Global Industry Assessment & Forecast to identify key trends and challenges. The report offers insights into the competitive landscape, prospects, and key investment considerations for businesses operating in the Biotechnology market. Some of the key statistics in the report highlight that Global Biotechnology Market was valued at USD 1,094.6 Billion in 2022 and is projected to reach a value of USD 2772.7 Billion by 2028 at a CAGR of 14.2% over the forecast period. The global Biotechnology market will continue to expand due to technological advancements, increasing research and development activities, and rising demand for personalized medicine.
Request Sample Report of Biotechnology Market @ https://www.vantagemarketresearch.com/biotechnology-market-2141/request-sample
The Global Biotechnology market is dominated by well-known players like Gilead Sciences Inc. (U.S.), Amgen Inc. (U.S.), Qiagen N.V. (Netherlands), Thermo Fisher Scientific Inc. (U.S.), Biogen Inc. (U.S.), Illumina Inc. (U.S.), Regeneron Pharmaceuticals Inc. (U.S.), Novo Nordisk A/S (U.S.), Vertex Pharmaceuticals Inc. (U.S.), Biocartis Group NV (Belgium), Moderna Inc. (U.S.), Bristol-Myers Squibb Co. (U.S.), among others.
Let’s Take a Look at the Top Market Players that are Captivating the Biotechnology Market
- Gilead Sciences Inc. (U.S.)
. is a biopharmaceutical company that develops and commercializes innovative therapies in areas such as HIV/AIDS, liver diseases, oncology, inflammatory and respiratory diseases. The company was founded in 1987 and is headquartered in Foster City, California. Gilead Sciences has made significant contributions to the healthcare industry by developing antiviral drugs that have revolutionized treatment for HIV/AIDS and earned the company a reputation as a leader in infectious disease therapeutics. Some of its notable HIV drugs include Truvada, Atripla, and Descovy. The biotechnology market is a rapidly growing sector that is expected to grow exponentially due to the increasing demand for innovative therapies, aging populations, and rising healthcare expenditures. Advances in genomics, proteomics, and personalized medicine have also led to the development of more targeted and effective therapies. Gilead Sciences is a major player in the biotechnology market, with a strong portfolio of products and a robust pipeline of potential new treatments. In addition to its HIV/AIDS drugs, Gilead Sciences has several other significant products, including Harvoni and Epclusa, which treat chronic hepatitis C virus infection, and Yescarta, a gene therapy treatment for certain types of lymphoma.
- Amgen Inc. (U.S.)
Amgen Inc. is a leading biotechnology company specializing in developing innovative therapies for serious illnesses such as cancer, cardiovascular disease, inflammatory conditions, and bone health. The company was founded in 1980 and has its headquarters in Thousand Oaks, California. Amgen is one of the world's largest biotechnology companies, with over 20,000 employees in over 75 countries. The biotechnology market is a rapidly growing industry that involves using living organisms and biological processes to develop new products and technologies. The industry is driven by advances in science & technology and the growing demand for innovative therapies & treatments for various medical conditions. Amgen has a diverse portfolio of products and technologies, including biologics, biosimilars, and small-molecule drugs. The company strongly focuses on research & development, with many pipeline products in development for various conditions. The biotechnology market is highly competitive, with many companies vying for a market share.
- Qiagen N.V. (Netherlands)
Qiagen N.V. is a leading global provider of sample & assay technologies for molecular diagnostics, applied testing, and academic and pharmaceutical research. Customers use the company's products and services in over 130 countries to detect, identify and analyze DNA, RNA, and proteins in various biological samples. Qiagen operates in four main business areas: Molecular Diagnostics, Life Science Research, Applied Testing, and Pharma and Academia. Its product portfolio includes sample preparation and assay technologies for various applications, including cancer testing, infectious disease testing, genetic testing, and biomarker analysis. Qiagen is well-positioned to benefit from the growth of the biotechnology market due to its strong presence in the molecular diagnostics and life science research segments. In addition, the company's innovative products and services have helped to accelerate scientific discoveries and improve diagnostic testing in various areas, including oncology, infectious diseases, and personalized medicine.
- Thermo Fisher Scientific Inc. (U.S.)
Thermo Fisher Scientific Inc. is a leading biotechnology company that provides analytical instruments, reagents, consumables, software, and services to customers in the life science, clinical research, and industrial market segments. The company operates through four business segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. The Life Sciences Solutions segment provides a range of instruments, reagents, consumables, software, and services that enable customers to identify, analyze, and manipulate genetic information. This segment serves customers in academic and government research institutions, pharmaceutical and biotech companies, and clinical labs. The Analytical Instruments segment offers analytical instruments, software, services, and consumables to customers in various markets, including environmental, food safety, forensic, clinical, and academic laboratories. The Specialty Diagnostics segment provides diagnostic test kits, reagents, culture media, instruments, and products to clinical laboratories, hospitals, blood banks, and other healthcare institutions. The Laboratory Products and Services segment offers a range of lab equipment, chemicals, supplies, and services to customers in the academic, government, pharmaceutical, and biotech industries. In addition to these business segments, Thermo Fisher Scientific offers a range of services, including sample preparation, assay development, and contract research services. Thermo Fisher Scientific is well-positioned to benefit from this growth, as its products and services are essential tools for researchers, clinicians, and manufacturers in the biotech industry.
- Biogen Inc. (U.S.)
Biogen Inc. is a leading biotechnology company that specializes in developing therapies for neurological and neurodegenerative diseases. The company's portfolio includes treatments for multiple sclerosis, spinal muscular atrophy, and Alzheimer's disease. The biotechnology market is a rapidly growing industry that involves applying biological systems and living organisms to develop new products and technologies. There is a high demand for therapies that treat rare diseases and chronic conditions, leading to significant advancements in biotechnology research and development. Biogen has a global presence with operations in North America, Europe, and Asia. Biogen is known for developing innovative therapies that can improve patients' lives with neurological and neurodegenerative diseases.
- Illumina Inc. (U.S.)
Illumina Inc. is a leading biotechnology company specializing in developing various genetic analysis tools and services. The company provides:
- Genomic sequencing and analysis platforms.
- Post-sequencing tools and services.
- Advanced genotyping technologies.
Its products have various applications in research and clinical laboratories, including cancer genomics, reproductive health, agriculture, and forensic genomics. Illumina's strong position in the biotechnology market is evidenced by its financial performance and market share. Illumina's success can be attributed to its innovative products and services, strategic partnerships, and investments in research and development.
- Regeneron Pharmaceuticals Inc. (U.S.)
Inc. is a leading science-based biotechnology company that discovers, develops, and commercializes innovative medicines in oncology, ophthalmology, inflammatory diseases, and rare genetic diseases. With a focus on research & development, the company has developed multiple therapeutic options for patients suffering from various diseases. Regeneron Pharmaceuticals is one of the top-performing companies in the biotechnology market and strongly focuses on developing innovative treatments, utilizing cutting-edge technologies in biologics, and is known for its dynamic research and development program. With a focus on collaboration with various organizations and partnerships with other established companies, Regeneron has expanded its portfolio of drugs and products while increasing its operational efficiencies. In addition, the company has a strong presence in the United States, Europe, and Japan, allowing it to globalize and expand its reach.
- Novo Nordisk A/S (Denmark)
Novo Nordisk A/S is a multinational pharmaceutical company headquartered in Bagsvaerd, Denmark. The company is known for specializing in the production of diabetes drugs and is considered to be the market leader in the field. Novo Nordisk's portfolio includes a range of treatments for diabetes, hemophilia, growth hormone deficiency, and obesity. The company also develops drugs for other chronic conditions such as non-alcoholic steatohepatitis (NASH) and cardiovascular disease. In recent years, Novo Nordisk has invested heavily in developing new biopharmaceuticals and biosimilars.
- Bristol-Myers Squibb Co. (U.S.)
Bristol-Myers Squibb (BMS) is a global biopharmaceutical company that develops, manufactures, and distributes prescription drugs and biologics in various therapeutic areas, including oncology, cardiology, immunology, and neuroscience. The company focuses on developing innovative medicines to address unmet medical needs and improve patient outcomes. BMS has both small molecule and biologics pipelines, with several promising candidates in late-stage development for various indications. BMS is a significant player in the biotechnology market, with a strong presence in the oncology space. The company's cancer immunotherapy drugs, Opdivo and Yervoy, have shown promising results in treating various cancers, including lung cancer, melanoma, and renal cell carcinoma. In addition, BMS has recently acquired Celgene, a leading biotech company, to expand its pipeline and strengthen its position in the market.
Read Our Latest Blog: Top Companies in Veterinary Regenerative Medicine Market
Do You Have Any Queries or Specific Requirements? You may enquire to our sales team before purchasing.
6218 Georgia Avenue NW Ste 1 - 564
Washington DC 20011-5125
United States Tel: +1 202 380 9727
Email: [email protected]
Website: Vantage Market Research